These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 384557)

  • 21. In vivo activity of mutacin B-Ny266.
    Mota-Meira M; Morency H; Lavoie MC
    J Antimicrob Chemother; 2005 Nov; 56(5):869-71. PubMed ID: 16155061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Typing of Actinomyces pyogenes by its production and susceptibility to bacteriocin-like inhibitors.
    Lämmler C
    Zentralbl Bakteriol; 1990 Jun; 273(2):173-8. PubMed ID: 2400533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of lactic acid bacteria isolated from specific natural niches in food production and preservation.
    Topisirovic L; Kojic M; Fira D; Golic N; Strahinic I; Lozo J
    Int J Food Microbiol; 2006 Dec; 112(3):230-5. PubMed ID: 16764959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.
    Weerkamp A; Heinen-von Borries UT; Vogels GD
    Antonie Van Leeuwenhoek; 1978; 44(1):35-48. PubMed ID: 655698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Basis of the antibacterial activity of the macrolides: sensitivity and resistance].
    Cocuzza G; Mattina R
    G Ital Chemioter; 1982; 29 Suppl 1():19-23. PubMed ID: 6765369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Production of antibacterial substances by resident corynebacteria isolated from human skin].
    Kwaszewska A; Szewczyk EM
    Med Dosw Mikrobiol; 2007; 59(3):251-7. PubMed ID: 18078120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antibiotics on the oropharyngeal flora in patients with acne.
    Levy RM; Huang EY; Roling D; Leyden JJ; Margolis DJ
    Arch Dermatol; 2003 Apr; 139(4):467-71. PubMed ID: 12707094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
    Barg N
    J Antimicrob Chemother; 1998 Aug; 42(2):257-60. PubMed ID: 9738847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriocins from human and rodent streptococci.
    Kelstrup J; Gibbons RJ
    Arch Oral Biol; 1969 Mar; 14(3):251-8. PubMed ID: 4978137
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains.
    Nascimento JS; Ceotto H; Nascimento SB; Giambiagi-Demarval M; Santos KR; Bastos MC
    Lett Appl Microbiol; 2006 Mar; 42(3):215-21. PubMed ID: 16478507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo studies on a phage type 71 staphylococcal bacteriocin.
    Dajani AS; Wannamaker LW
    Contrib Microbiol Immunol; 1973; 1():413-21. PubMed ID: 4281733
    [No Abstract]   [Full Text] [Related]  

  • 32. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
    Gemmell CG
    Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible role of bacteriocins in the disappearance in vivo of the L-phase of group A hemolytic streptococci.
    Clasener HA; Ensering HL
    Zentralbl Bakteriol Orig A; 1972 Oct; 222(1):34-9. PubMed ID: 4145150
    [No Abstract]   [Full Text] [Related]  

  • 34. New 2-methyldiethylammoniumethylthio-4-aryl-3h-1,5-benzodiazepine iodides with antibacterial activity. ii.
    Nardi D; Massarani E; Tajana A; Cappelletti R; Veronese M
    Farmaco Sci; 1975 Sep; 30(9):727-35. PubMed ID: 1098924
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A.
    Tagg JR; Pihl EA; McGiven AR
    J Gen Microbiol; 1973 Nov; 79(1):167-9. PubMed ID: 4589998
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteriocin of phage type 71 S. aureus.
    Dajani AS; Wannamaker LW
    Ann N Y Acad Sci; 1974 Jul; 236(0):389-94. PubMed ID: 4153752
    [No Abstract]   [Full Text] [Related]  

  • 37. Conditional killing effect of staphylococcin 1580 and repair of sublethal injury in Staphylococcus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Antimicrob Agents Chemother; 1977 Sep; 12(3):314-21. PubMed ID: 20837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriocin of Enterococcus from lactoserum able to cause oxidative stress in Staphylococcus aureus.
    Eraso AJ; Inés A
    Biochem Biophys Res Commun; 2004 Feb; 314(3):897-901. PubMed ID: 14741721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of BLIS typing to studies of the survival on surfaces of salivary streptococci and staphylococci.
    Tagg JR; Ragland NL
    J Appl Bacteriol; 1991 Oct; 71(4):339-42. PubMed ID: 1960108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriocin typing of enterococci.
    Sadatsune T; Kuwabara M; Watanabe T; Matsuo Y
    Hiroshima J Med Sci; 1978 Dec; 27(4):241-6. PubMed ID: 372147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.